Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents
Anton De Spiegeleer, Antoon Bronselaer, James Teo, et al.
Journal of the American Medical Directors Association (2020) Vol. 21, Iss. 7, pp. 909-914.e2
Open Access | Times Cited: 168

Showing 51-75 of 168 citing articles:

Familial hypercholesterolaemia and COVID-19: A two-hit scenario for endothelial dysfunction amenable to treatment
Alpo Vuorio, Frederick J. Raal, Markku Kaste, et al.
Atherosclerosis (2021) Vol. 320, pp. 53-60
Open Access | Times Cited: 31
Association between cardiometabolic risk factors and COVID-19 susceptibility, severity and mortality: a review
Yasaman Sharifi, Moloud Payab, Erfan Mohammadi-Vajari, et al.
Journal of Diabetes & Metabolic Disorders (2021) Vol. 20, Iss. 2, pp. 1743-1765
Open Access | Times Cited: 30
Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts and potential therapeutic targets
Maria Proto, Donatella Fiore, Chiara Piscopo, et al.
Progress in Lipid Research (2021) Vol. 82, pp. 101099-101099
Open Access | Times Cited: 29
Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research
Jordan Loader, Frances C. Taylor, Erik Lampa, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 11
Open Access | Times Cited: 19
Association of Statins for Primary Prevention of Cardiovascular Diseases With Hospitalization for COVID‐19: A Nationwide Matched Population‐Based Cohort Study
Kim Bouillon, Bérangère Baricault, Laura Semenzato, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 12
Open Access | Times Cited: 19
Computational prediction of the molecular mechanism of statin group of drugs against SARS-CoV-2 pathogenesis
Dipanjan Ghosh, Debabrata Ghosh Dastidar, Kamalesh Roy, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 18
Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residents
Paul Alexander, Robin Armstrong, George Fareed, et al.
Medical Hypotheses (2021) Vol. 153, pp. 110622-110622
Open Access | Times Cited: 25
Adverse Cardiovascular Effects of Anti-COVID-19 Drugs
Dongling Liu, Xiang Zeng, Zufeng Ding, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 25
Statins as Adjuvant Therapy for COVID-19 to Calm the Stormy Immunothrombosis and Beyond
Alpo Vuorio, Petri T. Kovanen
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 23
Decreased Mortality Rate Among COVID-19 Patients Prescribed Statins: Data From Electronic Health Records in the US
Ivana Marić, Tomiko Oskotsky, Idit Kosti, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 23
Association of Statins and 28-Day Mortality Rates in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Zoe Memel, Jenny J. Lee, Andrea S. Foulkes, et al.
The Journal of Infectious Diseases (2021) Vol. 225, Iss. 1, pp. 19-29
Open Access | Times Cited: 23
Acute and Long-Term Consequences of COVID-19 on Arterial Stiffness—A Narrative Review
Ioana Mădălina Zota, Cristian Stătescu, Radu Andy Sascău, et al.
Life (2022) Vol. 12, Iss. 6, pp. 781-781
Open Access | Times Cited: 16
Perspectives of (/memorandum for) systems thinking on COVID‐19 pandemic and pathology
Felix Tretter, Eva M.J. Peters, Joachim P. Sturmberg, et al.
Journal of Evaluation in Clinical Practice (2022) Vol. 29, Iss. 3, pp. 415-429
Open Access | Times Cited: 16
Potential statin drug interactions in elderly patients: a review
Isabella Damiani, Alberto Corsini, Stefano Bellosta
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 12, pp. 1133-1145
Closed Access | Times Cited: 24
Statin Use Is Associated with a Decreased Risk of Mortality among Patients with COVID-19
Chieh-Chen Wu, An-Jen Lee, Chun-Hsien Su, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 7, pp. 1450-1450
Open Access | Times Cited: 20
Cardiovascular Dysfunction in COVID-19: Association Between Endothelial Cell Injury and Lactate
Kun Yang, Matthew T. Holt, Min Fan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
A gut feeling of statin
Jianqing She, Lizhe Sun, Yue Yu, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
SARS-CoV-2/COVID-19: a primer for cardiologists
Antoine A.F. de Vries
Netherlands Heart Journal (2020) Vol. 28, Iss. 7-8, pp. 366-383
Open Access | Times Cited: 23
Association Between Antecedent Statin Use and Decreased Mortality in Hospitalized Patients with COVID-19
Aakriti Gupta, Mahesh V. Madhavan, Timothy J. Poterucha, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 23
A systematic review and meta‐analysis of the use of renin‐angiotensin system drugs and COVID‐19 clinical outcomes: What is the evidence so far?
Amanj Kurdi, Nouf Abutheraa, Lina Akil, et al.
Pharmacology Research & Perspectives (2020) Vol. 8, Iss. 6
Open Access | Times Cited: 22
The benefit of statins in SARS-CoV-2 patients: further metabolic and prospective clinical studies are needed
Maurizio Bifulco, Michele Ciccarelli, Dario Bruzzese, et al.
Endocrine (2020) Vol. 71, Iss. 2, pp. 270-272
Open Access | Times Cited: 22
Statins as an adjunctive therapy for COVID-19: the biological and clinical plausibility
Tarek Kashour, Rabih Halwani, Yaseen M. Arabi, et al.
Immunopharmacology and Immunotoxicology (2021) Vol. 43, Iss. 1, pp. 37-50
Closed Access | Times Cited: 19
Pharmacological Predictors of Morbidity and Mortality in COVID‐19
Christopher Oddy, James McCaul, Polly Keeling, et al.
The Journal of Clinical Pharmacology (2021) Vol. 61, Iss. 10, pp. 1286-1300
Open Access | Times Cited: 18
Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs
Geert Byttebier, Luc Belmans, M Alexander, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 9, pp. 2841-2850
Open Access | Times Cited: 18
Discontinuation of atorvastatin use in hospital is associated with increased risk of mortality in COVID‐19 patients
Laura Andrews, Laurel Goldin, Yan Shen, et al.
Journal of Hospital Medicine (2022) Vol. 17, Iss. 3, pp. 169-175
Open Access | Times Cited: 12

Scroll to top